Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CRBU
#3646
Caribou Biosciences, Inc. Common Stock
2.1
2
USD
+8.72%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+8.72%
Aylık Değişim
+12.17%
6 aylık değişim
-14.17%
Yıllık Değişim
+165.00%
Önceki Kapanış
1.9
5
Open
2.1
2
Bid
Ask
Low
2.1
2
High
2.1
2
Hacim
21
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CRBU
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
60.66 M
61.3 M
90.31 M
93 M
96.64 M
—
Valuation ratios
Enterprise value
674.99 M
374.6 M
479.37 M
158.09 M
141.29 M
495.57 M
Price to earnings ratio
—
-4.03
-4.04
-0.96
-1
-3.64
Price to sales ratio
—
29.02
11.92
14.37
13.31
57.51
Price to cash flow ratio
—
-4.42
-4.41
-1.04
-1.34
-4.52
Price to book ratio
—
1.34
1.12
0.57
1.22
1.69
Enterprise value to EBITDA ratio
-10.23
-3.31
-4.02
-0.81
-0.98
-3.23
Profitability ratios
Return on assets %
-0.15
-0.27
-0.24
-0.48
-0.84
-0.68
Return on equity %
-0.17
-0.33
-0.28
-0.59
-1.21
-0.92
Return on invested capital %
-449.68
-462.21
-419.33
-680.35
-897.62
-1 206.88
Gross margin %
100
100
100
100
100
400
Operating margin %
-697.84
-768.17
-336.63
-1 667.16
-1 329.37
-5 667.26
EBITDA margin %
-687.59
-756.46
-326.4
-1 627.87
-1 296.7
-5 527.98
Net margin %
-697.26
-717.79
-296.05
-1 491.95
-1 327.4
-5 653.43
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.15
9.25
11.97
7.16
5.71
25.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.02
0.03
0.09
0.03
0.05
0.05
Solvency ratios
Debt to assets ratio
0
0.07
0.06
0.08
—
—
Debt to equity ratio
0
0.09
0.07
0.1
—
—
Long term debt to total assets ratio
0
0
0
0
—
—
Long term debt to total equity ratio
0
0
0
0
—
—
Per share metrics
Operating cash flow per share
—
-1.5
-1.26
-1.53
-1.19
-1.19
EBIT per share
—
-1.75
-1.57
-1.84
-1.59
-1.59
EBITDA per share
—
-1.72
-1.52
-1.8
-1.55
-1.56
Total debt per share
—
0.46
0.37
0.29
—
—
Cash per share
—
5.21
5.05
2.76
1.53
7.51
Net current asset value per share
—
4.28
4.59
2.43
1.56
7.64
Tangible book value per share
—
4.95
4.99
2.8
1.31
6.96
Working capital per share
—
3.82
4.21
2.09
1.28
6.45
Book value per share
—
4.95
4.99
2.8
1.31
6.96
Haberler
Three Best Genomics Stocks for Your Portfolio in 2026
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Truist, Caribou Biosciences için Al tavsiyesini yineledi, hedef 7 dolar
Truist reiterates Buy on Caribou Biosciences stock, $7 target
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences kazancı $0,04 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
Caribou Biosciences earnings beat by $0.04, revenue topped estimates
EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates
Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates